HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Propacetamol

HCID 68865
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
66532-85-2
Standard SMILES
CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1
InChIKey
QTGAJCQTLIRCFL-UHFFFAOYSA-N
Molecular formula
C14H20N2O3
Average molar mass
264.32 g/mol
Monoisotopic mass
264.1473925

Overview

Propacetamol is an alpha-amino acid ester.

Names & identifiers

Preferred name
Propacetamol
IUPAC
(4-acetamidophenyl) 2-(diethylamino)acetate
English name
Propacetamol
Molecular formula
C14H20N2O3
Molecular weight
264.32

Names & synonyms

Propacetamol66532-85-2PropacetamolumDTXSID30578005CHW4JMR82DTXCID70315894-acetamidophenyl 2-(diethylamino)acetateRefChem:176249N02BE05N, N-diethylglycine 4'-hydroxyacetanilide ester266-390-1(4-acetamidophenyl) 2-(diethylamino)acetate
Show more names
PropacetamoPro-DafalganPropacatemolPropacetamol USP/EP/BP4-Acetamidophenyl N,N-diethylglycinate4-acetamidophenyl N,N-diethylaminoacetateN,N-Diethylglycine 4-(acetylamino)phenyl ester(Diethylamino)acetic acid 4-(acetylamino)phenyl
Propacetamol [INN]Glycine, N,N-diethyl-, 4-(acetylamino)phenyl esterPropacetamol (INN)Propacetamolum [Latin]EINECS 266-390-1Propacetamol [INN:BAN]UNII-5CHW4JMR82Propacetamol (Standard)

Database identifiers

CAS
66532-85-2
PubChem CID
68865
DTXSID
DTXSID3057800
ChEMBL
CHEMBL1851805
ChEBI
CHEBI:135089
UNII
5CHW4JMR82
EC Number
266-390-1
Nikkaji
J32.504J

Properties

Computed structural properties

XLogP
1.1
Topological polar surface area
58.6 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
7
Heavy atoms
19
Formal charge
0
Complexity
295

Experimental & physicochemical properties

Chemical ClassesOther Uses -> Pharmaceuticals
DrugsPharmaceuticals -> Listed in ZINC15
SolubilitySoluble
Boiling Point434.5ºC at 760 mmHg

Physicochemical properties

Melting point
55 · 55-57 °C
Boiling point
434.5 · 434.5±30.0 °C(Predicted)
Density
1.132 · 1.132±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
2 O · H2O : 100 mg/mL (378.33 mM; Need ultrasonic)
pka
14.2 · 14.20±0.70(Predicted)
form
Solid
color
White to off-white
CAS DataBase Reference
66532 · 66532-85-2(CAS DataBase Reference)
FDA UNII
5 CHW4JMR82 · 5CHW4JMR82
NCI Drug Dictionary
propacetamol
ATC code
2 BE05 · N02BE05
Comptox DTXSID
3057800 · DTXSID3057800

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Hazards SummaryAllergic contact dermatitis reported in nurses (contact and airborne dermatitis); [Kanerva, p. 1829]

Toxicology

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.
Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Propacetamol

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

Protein BindingPropacetamol is very rapidly converted into paracetamol and this later component tends to present a very negligible binding to plasma proteins.
Pharmacodynamics · 1 item

Propacetamol is hydrolyzed to paracetamol and then it presents a weak inhibition of COX-1 and COX-2 which is translated into a low anti-inflammatory activity. Therefore, in high inflammatory conditions, such as rheumatoid arthritis, these agents show limited in vivo suppression of inflammation and platelet activity. The formation of N-arachidonoylphenolamine, donates paracetamol with analgesic and antipyretic properties.

Mechanism of Action · 1 item

As propacetamol is a prodrug, its mechanism of action is directly linked to the activity of paracetamol. The mechanism of action of paracetamol is described by the inhibition of prostaglandin synthesis. This inhibition is attained by inhibition of COX-1 and COX-2 in an environment where arachidonic acid and peroxides are kept low. It is considered that paracetamol presents a very complex mechanism of action involving effects in the peripheral system, described by direct COX inhibition; the central system, characterized by inhibition of COX, serotonergic descending neuronal pathway, L-arginine/NO pathway and cannabinoid system; and a redox mechanism. In the brain and spinal cord, paracetamol can combine with arachidonic acid to form N-arachidonoylphenolamine. This metabolite is an activator of capsaicin receptor (TRPV1) and cannabinoid CB1.

Biological Half-LifeThe half-life of propacetamol is of 3.6 h.
Metabolism/Metabolites · 1 item

After administration, propacetamol is completely converted by plasma esterases into N, N-diethylglycine and paracetamol. The latest is the active metabolite. It is reported that the active metabolite of propacetamol can be transformed to N-acetil-p-benzoquinone imine by CYP2E1 which is a hepatotoxic metabolite.

MeSH Pharmacological Classification · 2 items

Compounds capable of relieving pain without the loss of CONSCIOUSNESS.

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and Excretion · 4 items

The bioavailability of 2g of propacetamol is similar to the bioavailability found in 1 g of intravenous paracetamol. Peak plasma concentration is obtained as and from the end of infusion. Pharmacokinetic analysis with intravenous propacetamol showed a significantly higher and earlier maximum plasma concentration than orally administered paracetamol. The Cmax, Tmax and AUC are 12.72 mcg/ml, 0.25 h and 25.5 mcg.h/ml. After infusion with propacetamol, significant concentrations of paracetamol are observed in cerebrospinal fluid.

The metabolites of propacetamol are mainly excreted in the urine. From the elimination rate, 90% of the administered dose is excreted in 24 hours mainly as glucuronide and sulfate conjugates. Less than 5% is eliminated as unchanged paracetamol.

The volume of distribution of propacetamol is 1.29 l/kg.

The clearance rate of propacetamol is 0.28 l.h/kg.

Uses & manufacturing

UsesThis pro-drug of acetaminophen is administered intravenously. [Kanerva, p. 1829]
Applications · 2 items

DescriptionPropacetamol is the prodrug of paracetamol (acetaminophen), used for intravenous administration. It results from eombination of paracetamol and diethylglycine. Causes contact dermatitis and airborne dermatitis in nurses. Allergenic properties are due to the N,N' -diethylglycine moiety, and not to the paracetamol moiety.

UsesPropacetamol hydrochloride is a water-soluble prodrug for intravenous administration resulting in the liberation of paracetamol.

Upstream & downstream products

Upstream raw materials

Phenyl esterChloroacetic acidPotassium iodidePotassium carbonateDiethylamineChloroacetyl chlorideAniline

Additional notes

DefinitionChEBI: Propacetamol is an alpha-amino acid ester.

Related reactions

1 records
New reaction record
HRID 2311000 reaction equation
HRID 2311000As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes